News

Medtronic, Inc. has received CE (Conformité Européenne) Mark for the TYRX™ Absorbable Antibacterial Envelope. This innovative mesh envelope covers an implantable cardiac device to help stabilize the device after implantation and reduce...

Abiomed Inc., a leading provider of breakthrough heart support technologies, announced clinical trial results from RECOVER RIGHT, an Investigational Device Exemption (IDE) study of the Impella RP™ (Right Percutaneous) System. The clinical...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that that it will display the LifeVest® Wearable Defibrillator in Booth #300 at the 2014 Heart Failure Society of America (HFSA) Annual...

Stereotaxis announced that it has received 510(k) clearance by the Food and Drug Administration (FDA) to market its Vdrive™ Robotic Navigation System with V-Loop™ Variable Loop Catheter Manipulator in the U.S. The Company submitted a 510(k)...

First FDA-Cleared Mobile ECG Device to be offered in India - Provides Physicians an Instant Screening Tool for Arrhythmias, Major Step in Cardiac Care Apollo Hospitals and AliveCor, Inc. announced the launch of an exclusive collaboration...

Preventice, developer of the PatientCare™ Platform and the BodyGuardian® Remote Monitoring Sensor and an innovator in software solutions for remote patient care, and eCardio Diagnostics® LLC, a leading provider of remote cardiac monitoring...

Renal denervation reduces recurrent atrial fibrillation (AF) when performed with pulmonary vein isolation ablation in patients with AF and hypertension, according to research presented at ESC Congress by Dr. Alexander Romanov from the Russian...

X-VeRT Study Results Presented as a Hot Line Session at the ESC Congress 2014 and Published in European Heart Journal Janssen Research & Development, LLC (Janssen) and its development partner, Bayer HealthCare, announced results from the...

Registry provides new insights into AF treatment decisions, including patients' quality of life and treatment satisfaction1,2 ESC Congress 2014, 02 September 2014, Barcelona, Spain: Daiichi Sankyo announced one-year results of the PREvention...

GARFIELD-AF Registry presentations at ESC CONGRESS 2014 provide insight into treatment and outcomes of patients at risk of stroke in everyday clinical practice Data from nearly 12,500 patients enrolled in the Global Anticoagulant Registry...